Abstract
Patients with Philadelphia chromosome-positive (Ph+) and/or BCR-ABL+ acute lymphoblastic leukemia (ALL) have extremely poor prognoses. Most of these patients have additional, heterogenous karyotype abnormalities, the majority of which have uncertain clinical significance. In this study we analyzed the clinical characteristics, karyotype abnormalities, and outcome of 77 patients with Ph+ and/or BCR-ABL+ ALL registered in Poland in 1997-2004. In 31/55 patients with known karyotype, the sole t(9;22)(q34;q11) abnormality had been diagnosed; in one patient, variant translocation t(4;9;22)(q21q31.1;q34;q11), and additional abnormalities in 23 (42%) patients, had been diagnosed. The characteristics of the patients with Ph chromosome and additional abnormalities were not significantly different when compared with the entire analyzed group. Out of 77 patients, 54 (70%) achieved first complete remission (CR1) after one or more induction cycles. The overall survival (OS) probability of 2 years was 63, 43, and 17% for patients treated with allogeneic stem cell transplantation (alloSCT), autologous SCT, and chemotherapy, respectively (log rank p=0.002). Median OS from the time of alloSCT was significantly longer for patients transplanted in...Continue Reading
References
May 4, 1991·Lancet·J MaurerA Reiter
Jan 1, 1991·Annals of Human Genetics·B J KeatsJ Ott
May 4, 1999·The Journal of Experimental Medicine·S LiR A Van Etten
Feb 16, 2000·Leukemia & Lymphoma·S FaderlZ Estrov
May 30, 2001·Leukemia & Lymphoma·B VidarssonW L Longo
Feb 28, 2002·Blood·Beate GleissnerUNKNOWN German Multicenter Trials of Adult Acute Lymphoblastic Leukemia Study Group
Sep 20, 2002·Blood·Hervé DombretUNKNOWN Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group)
Apr 15, 2003·Bone Marrow Transplantation·I Avivi, A H Goldstone
Jun 7, 2003·Blood·Giuseppe CiminoUNKNOWN GIMEMA Group
Dec 3, 2003·Annals of Hematology·Nicola Gökbuget, Dieter Hoelzer
Dec 3, 2003·Annals of Hematology·T RobakM Cioch
Jan 14, 2004·British Journal of Haematology·Meir WetzlerClara D Bloomfield
Jan 31, 2004·Pediatric Blood & Cancer·Luca Lo NigroGiuseppe Basso
Mar 27, 2004·Leukemia·N A HeeremaUNKNOWN UKALL
Aug 24, 2004·Annals of Hematology·Marino ClavioMarco Gobbi
Sep 24, 2004·Drugs & Aging·Tadeusz Robak
Mar 4, 2005·Leukemia·F PaneUNKNOWN GIMEMA group
Mar 25, 2005·Leukemia·D PrimoA Orfao
May 5, 2005·Acta Haematologica·Pia RaananiIsaac Ben-Bassat
Jul 28, 2005·Annals of Hematology·G SpecchiaV Liso
Citations
Feb 27, 2009·Blood·Adele K FieldingAnthony H Goldstone
Jan 15, 2016·Leukemia & Lymphoma·Katarzyna Kapelko-SlowikMaciej Ugorski
Nov 12, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sebastian GiebelMohamad Mohty
Jan 1, 2008·Hematology/oncology and Stem Cell Therapy·Tarek M OwaidahNasser B Elkum
Jun 17, 2016·Cancer·Sebastian GiebelArnon Nagler
Dec 23, 2016·American Journal of Hematology·Nicholas J ShortElias Jabbour
May 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna M ButturiniWilliam L Carroll
Aug 9, 2019·Annals of Hematology·Sebastian GiebelArnon Nagler
Apr 29, 2020·Pharmacotherapy·Kathryn A CulosMichael Byrne
Nov 19, 2020·Clinics·Ting ShiXiujin Ye